Full Text View
Tabular View
No Study Results Posted
Related Studies
Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)
This study is ongoing, but not recruiting participants.
Study NCT01354405   Information provided by Radboud University

First Received on May 13, 2011.   Last Updated on April 2, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Polycystic Liver Disease
Additional conditions recognized in this trial
Cysts
Liver Diseases
Polycystic Kidney Diseases
Polycystic Kidney, Autosomal Dominant
More general conditions related to this trial
Digestive System Diseases
Kidney Diseases
Kidney Diseases, Cystic
Neoplasms
Pathological Conditions, Anatomical
Urologic Diseases
Interventions listed in this trial
Lanreotide
Additional drug interventions recognized in this trial
Angiopeptin
More general drug interventions related to this trial
Antineoplastic Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Radboud University
Ipsen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services